Anbio Biotechnology Class A Ordinary Shares NNNN · SEC Filings

website

Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a glob...

Price4.08

Market Cap594.82 M

Float40.21 M

CountryDE

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Apr 9, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 7, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 28, 2025

News

TYPE

HEADLINE

FILED AT

6-K

Anbio Biotechnology Shareholders Approve Major Capital Restructuring and Share Consolidation

May 19, 2026

6-K

Anbio Biotechnology Announces Shareholder Meetings to Approve Capital Restructuring and Reverse Stock Split

Apr 27, 2026

6-K

Anbio Biotechnology Changes Independent Registered Public Accounting Firm

Feb 17, 2026

6-K

Anbio Biotechnology Appoints Michael Zhang to Board of Directors

Jan 26, 2026

6-K

Anbio Biotechnology Reports Unaudited Financial Results for Six Months Ended June 30, 2025

Dec 30, 2025

6-K

Anbio Biotechnology terminates YCM CPA INC as auditor and appoints HTL International, LLC as new independent auditor

Nov 12, 2025

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 19, 2025

CORRESP

Form CORRESP - Correspondence

Feb 14, 2025

CORRESP

Form CORRESP - Correspondence

Feb 14, 2025

LETTER

Form UPLOAD - SEC-generated letter

Dec 4, 2024

LETTER

Form UPLOAD - SEC-generated letter

Jun 21, 2024

LETTER

Form UPLOAD - SEC-generated letter

Mar 22, 2024